Dont miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Tolvaptan in patients with autosomal dominant polycystic kidney disease

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators
N Engl J Med. 2012 Dec 20;367(25):2407-18

Specifications

Google Plus
LinkedIn

Comments (0)

There are no comments posted here yet

Leave your comments

  1. Posting comment as a guest. Sign up or login to your account.
Attachments (0 / 3)
Share Your Location
ukidneyisup